Clinical Trial Update: A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating memantine to protect the brain during radiation therapy for brain tumors, with the study currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Central Nervous System Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING